COMPASS Pathways plc (CMPS)
USD 3.09
(3.18%)
USD 3.09
(3.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | - USD | 0.0% |
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | -100.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q4 | 3.68 Million USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 100.0% |
| Addus HomeCare Corporation | 1.05 Billion USD | 100.0% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | 100.0% |
| Amedisys, Inc. | 2.23 Billion USD | 100.0% |
| American Oncology Network, Inc. | 1.27 Billion USD | 100.0% |
| Astrana Health, Inc. | 1.38 Billion USD | 100.0% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 100.0% |
| IMAC Holdings, Inc. | 5.19 Million USD | 100.0% |
| biote Corp. | 185.36 Million USD | 100.0% |
| Cryo-Cell International, Inc. | 31.34 Million USD | 100.0% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 100.0% |
| DocGo Inc. | 624.28 Million USD | 100.0% |
| The Ensign Group, Inc. | 3.72 Billion USD | 100.0% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 100.0% |
| InnovAge Holding Corp. | 763.85 Million USD | 100.0% |
| Assure Holdings Corp. | 255 Thousand USD | 100.0% |
| The Joint Corp. | 117.69 Million USD | 100.0% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 100.0% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | 100.0% |
| ModivCare Inc. | 2.75 Billion USD | 100.0% |
| NewGenIvf Group Limited | 5.13 Million USD | 100.0% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | 100.0% |
| Option Care Health, Inc. | 4.3 Billion USD | 100.0% |
| P3 Health Partners Inc. | 1.26 Billion USD | 100.0% |
| P3 Health Partners Inc. | 1.26 Billion USD | 100.0% |
| The Pennant Group, Inc. | 544.89 Million USD | 100.0% |
| Surgery Partners, Inc. | 2.74 Billion USD | 100.0% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | 100.0% |
| Talkspace, Inc. | 150.04 Million USD | 100.0% |
| Talkspace, Inc. | 150.04 Million USD | 100.0% |
| The Oncology Institute, Inc. | 324.23 Million USD | 100.0% |
| The Oncology Institute, Inc. | 324.23 Million USD | 100.0% |